Centene Corporation Reports 2013 Second Quarter Earnings of $0.70 Per Diluted Share Including $0.07 of AcariaHealth Transaction Costs  
7/23/2013 6:24:14 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. LOUIS, July 23, 2013 /PRNewswire/ -- Centene Corporation CNC today announced its financial results for the quarter ended June 30, 2013.

Premium and Service Revenues (in millions)

$ 2,634.3

Consolidated Health Benefits Ratio 88.8 %